miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma. - Wikidata - wikimedia - TriplyDB

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

http://www.wikidata.org/entity/Q36782334

about

β-arrestin1 at the cross-road of endothelin-1 signaling in cancer Endothelin therapeutics in cancer: Where are we?Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.Demethoxycurcumin inhibited human epithelia ovarian cancer cells' growth via up-regulating miR-551a.A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells.Chronic hypoxia alters fetal cerebrovascular responses to endothelin-1.Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.Molecular mechanisms of drug resistance in ovarian cancer.MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells.The Network of Non-coding RNAs in Cancer Drug Resistance MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis The Endometriotic Tumor Microenvironment in Ovarian Cancer MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

P2860

Q26740489-FAF2636A-576E-4C40-AD94-5DCE81E5C9E7 Q36902508-A69EBA69-B4BD-4138-9755-6D83F9379CBA Q37109600-7D6E698C-57A8-485E-83FE-F64DB72D50A2 Q37722180-A752EFCF-DFF6-461D-95A6-7494AEE13476 Q38546133-4FCAD673-E92F-42BB-8F39-C323A40A67AF Q38710398-4B5D9140-D07C-44F6-B7D0-C50BF11AD05B Q38715514-E1C51740-9CC3-45A7-A2CE-402A41AB1DA2 Q46056406-C3A29EEE-511F-405C-B079-AD5290E108A2 Q48010163-FBB7B3B5-B7AE-4946-8F2A-F0FA81D0A4E7 Q48274587-CE221777-0D01-4A6E-9413-1D60ED24DE67 Q50349138-63171024-96A8-45F9-9BE8-B0C4AF2AC0F2 Q58694197-0B1F181C-1F6A-4CDF-A315-DB3D80CD96B2 Q58788954-72F75D73-C6FA-4D51-B91B-F877B9A469A8 Q58796878-576F07E6-6AB5-4949-A19D-DBB188A5B192 Q58798691-83A6E9AF-0C2C-49FB-AA96-0DD6D02B69B9

P2860

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

http://www.wikidata.org/entity/Q36782334

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

@en

type

label

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

@en

prefLabel

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

@en

P1433

Q36782334-7D1568A8-3C14-407E-A65B-C8DF37EA95BB

P1476

Q36782334-E5FCE229-394D-494B-8E0F-D5E96F9E3714

P2093

Q36782334-56A8C34F-2572-4D9E-91BD-38E4AB39B949

Q36782334-A223B903-5E07-4519-A0E0-9A659BFA23AC

Q36782334-B02CB947-EBF9-4DEE-AF13-7C36E3B7C53D

Q36782334-B7DA0AA6-6EB6-4C2D-967F-5CAB42C31D7B

Q36782334-BD8EC129-1A59-4D96-80FA-98C1489ED075

Q36782334-D05C467D-02C4-4A0A-B9D5-6923C002231C

P2860

Q36782334-01778BA0-3BB7-4B63-B90E-7EA2EB91B8A8

Q36782334-1422A75D-B565-46F3-A543-B0812F304C82

Q36782334-19F24698-3474-4E43-8DC0-91E7F77FAB86

Q36782334-1F24CF34-DB08-4972-B4AF-8BB09385E33B

Q36782334-27B44247-7FE3-4497-AA86-06466061A999

Q36782334-3D940355-0EC1-4676-B5CC-4595C2330DD9

Q36782334-4B9BDAA5-3704-40C9-83DA-6D233C41A3B0

Q36782334-4C85029C-8419-4671-A5A5-14E65474D40C

Q36782334-535A4102-618B-44FF-955E-325B0DDC7E96

Q36782334-582E177F-7C1E-46B7-A67E-CCA2F34BB299

P304

Q36782334-F56FE0F1-5D86-427D-972A-EC8187AFE165

P31

Q36782334-C94C8EE3-0C4A-4E9C-B686-3AC3EC3634BD

P356

Q36782334-32FB938E-9837-4274-B9E5-0E21D9CE37AD

P407

Q36782334-609CDB8F-01F0-4845-95A3-EB2AD933CBB6

P433

Q36782334-6A68CFC5-1AB3-4E85-9572-8346AF7636DA

P478

Q36782334-A0DBFB47-42CA-4C29-B537-F988C6B6EC3C

P50

Q36782334-1300CAE3-799B-4350-B499-23A15360DA68

Q36782334-5FCA9A01-F7C2-473D-9CCA-9861B699395C

Q36782334-5FD3F43A-E104-4A28-9CEA-1B54E65E7BC7

Q36782334-C4C02D7B-102E-457C-AE9E-1D6392B9CCBC

Q36782334-F238C0E2-DC09-465B-A804-20F1D18625BC

P577

Q36782334-E9802721-A900-4ECA-92D4-BD0BA1E47825

P698

Q36782334-CFAA9B9A-F324-4FBB-8514-9FF5ADA88905

P932

Q36782334-4F8DDD09-F92B-4010-A8CA-E4E25DA4EE5E

P356

ONCOTARGET.6546

P1433

P1476

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

@en

P2093

Elisa Semprucci

http://www.w3.org/2001/XMLSchema#string

Giovanni Blandino

http://www.w3.org/2001/XMLSchema#string

Roberta Cianfrocca

http://www.w3.org/2001/XMLSchema#string

Rosanna Sestito

http://www.w3.org/2001/XMLSchema#string

Valentina Caprara

http://www.w3.org/2001/XMLSchema#string

Valeriana Di Castro

http://www.w3.org/2001/XMLSchema#string

P2860

Human MicroRNA targets

Identification of mammalian microRNA host genes and transcription units

MicroRNAs: target recognition and regulatory functions

Cancer statistics, 2012

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

Analyzing real-time PCR data by the comparative C(T) method

MicroRNA signatures in human ovarian cancer

miRDB: a microRNA target prediction and functional annotation database with a wiki interface

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.

P304

4009-4023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6546

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26675258

http://www.w3.org/2001/XMLSchema#string

P932

4826186

http://www.w3.org/2001/XMLSchema#string